Meta-analysis of Neural Systems Underlying Placebo Analgesia from Individual Participant FMRI Data
Overview
Affiliations
The brain systems underlying placebo analgesia are insufficiently understood. Here we performed a systematic, participant-level meta-analysis of experimental functional neuroimaging studies of evoked pain under stimulus-intensity-matched placebo and control conditions, encompassing 603 healthy participants from 20 (out of 28 eligible) studies. We find that placebo vs. control treatments induce small, widespread reductions in pain-related activity, particularly in regions belonging to ventral attention (including mid-insula) and somatomotor networks (including posterior insula). Behavioral placebo analgesia correlates with reduced pain-related activity in these networks and the thalamus, habenula, mid-cingulate, and supplementary motor area. Placebo-associated activity increases occur mainly in frontoparietal regions, with high between-study heterogeneity. We conclude that placebo treatments affect pain-related activity in multiple brain areas, which may reflect changes in nociception and/or other affective and decision-making processes surrounding pain. Between-study heterogeneity suggests that placebo analgesia is a multi-faceted phenomenon involving multiple cerebral mechanisms that differ across studies.
Mamud-Meroni L, Tarcaya G, Carrasco-Uribarren A, Rossettini G, Flores-Cortes M, Ceballos-Laita L Biomedicines. 2025; 13(2).
PMID: 40002804 PMC: 11853516. DOI: 10.3390/biomedicines13020392.
Bush N, Cushnie A, Boissoneault J, Aghabeigi S, Alexander C, Staud R J Pain Res. 2025; 18():189-201.
PMID: 39816204 PMC: 11733195. DOI: 10.2147/JPR.S483157.
Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia.
Neyama H, Wu Y, Nakaya Y, Kato S, Shimizu T, Tahara T Sci Adv. 2025; 11(3):eadp8494.
PMID: 39813331 PMC: 11734720. DOI: 10.1126/sciadv.adp8494.
Eken A, Yuce M, Yukselen G, Erdogan S Neurophotonics. 2024; 11(4):045015.
PMID: 39691581 PMC: 11651663. DOI: 10.1117/1.NPh.11.4.045015.
Coxon L, Amer M, Daniels J, Doust A, Mackenzie S, Horne A Front Pharmacol. 2024; 15:1460206.
PMID: 39691398 PMC: 11649436. DOI: 10.3389/fphar.2024.1460206.